Exenatide vs Nivolumab

## Exenatide vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Exenatide** and **Nivolumab**.

## Mechanism of Action

**Exenatide**: Synthetic exendin-4 GLP-1 receptor agonist enhancing glucose-dependent insulin secretion.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Exenatide — 2.4 hours; Nivolumab — 27 days.

## Chemical Properties

**Type**: Exenatide — Protein; Nivolumab — Antibody.